BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25405282)

  • 21. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2
    Devanand P; Oya Y; Sundaramoorthy S; Song KY; Watanabe T; Kobayashi Y; Shimizu Y; Hong SA; Suganuma M; Lim IK
    Exp Mol Med; 2018 Feb; 50(2):e449. PubMed ID: 29472702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines.
    Cho BO; Jeong YW; Kim SH; Park K; Lee JH; Kweon GR; Park JC
    Oncol Rep; 2008 Mar; 19(3):633-7. PubMed ID: 18288394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression.
    He Z; Liu Y; Xiao B; Qian X
    Biochem Biophys Res Commun; 2015 Feb; 457(3):235-41. PubMed ID: 25576360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akt Downregulates B-Cell Translocation Gene-2 Expression Via Erk1/2 Inhibition for Proliferation of Cancer Cells.
    Zubair H; Lim IK; Safi SZ; Rehman F; Imran M
    Ann Clin Lab Sci; 2020 Nov; 50(6):711-716. PubMed ID: 33334784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.
    Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A
    Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2.
    Tong Z; Jiang B; Wu Y; Liu Y; Li Y; Gao M; Jiang Y; Lv Q; Xiao X
    Int J Mol Sci; 2015 Jun; 16(7):14511-25. PubMed ID: 26132560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.
    Choi JA; Jung YS; Kim JY; Kim HM; Lim IK
    Oncogene; 2016 Jan; 35(1):83-93. PubMed ID: 25798836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells.
    el-Ghissassi F; Valsesia-Wittmann S; Falette N; Duriez C; Walden PD; Puisieux A
    Oncogene; 2002 Oct; 21(44):6772-78. PubMed ID: 12360398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid induction of PC3/BTG2 gene by hepatopoietin or partial hepatectomy and its mRNA expression in hepatocellular carcinoma.
    Zhang ZM; Wang G; Chen C; Yang ZX; Jin F; San JL; Xu W; Li Q; Li ZP; Wang D
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):288-93. PubMed ID: 19502170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
    Donato LJ; Suh JH; Noy N
    Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shifting p53-induced senescence to cell death by TIS21(/BTG2/Pc3) gene through posttranslational modification of p53 protein.
    Choi OR; Ryu MS; Lim IK
    Cell Signal; 2016 Sep; 28(9):1172-1185. PubMed ID: 27208501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma Irradiation Upregulates B-cell Translocation Gene 2 to Attenuate Cell Proliferation of Lung Cancer Cells Through the JNK and NF-κB Pathways.
    Wang P; Cai Y; Lin D; Jiang Y
    Oncol Res; 2017 Aug; 25(7):1199-1205. PubMed ID: 28251885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BTG2, its family and its tutor.
    Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
    Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein methylation and interaction with the antiproliferative gene, BTG2/TIS21/Pc3.
    Paik WK; Kim S; Lim IK
    Yonsei Med J; 2014 Mar; 55(2):292-303. PubMed ID: 24532495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
    Puisieux A; Magaud JP
    Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BTG2 overexpression increases the radiosensitivity of breast cancer cells in vitro and in vivo.
    Hu X; Xing L; Jiao Y; Xu J; Wang X; Han A; Yu J
    Oncol Res; 2013; 20(10):457-65. PubMed ID: 24308156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
    Sasajima H; Nakagawa K; Yokosawa H
    Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
    Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
    Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.
    Quy LN; Choi YW; Kim YH; Chwae YJ; Park TJ; Lim IK
    Cell Signal; 2013 Dec; 25(12):2391-9. PubMed ID: 23917204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.